SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-088977
Filing Date
2016-03-18
Accepted
2016-03-18 17:29:35
Documents
5
Period of Report
2016-04-12
Effectiveness Date
2016-03-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT v433847_def14a.htm DEF 14A 412096
2 GRAPHIC logo.jpg GRAPHIC 22195
3 GRAPHIC signature_02.jpg GRAPHIC 6317
4 GRAPHIC signature_03.jpg GRAPHIC 7916
5 GRAPHIC image_001.jpg GRAPHIC 104190
  Complete submission text file 0001144204-16-088977.txt   601735
Mailing Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-55275 | Film No.: 161517012
SIC: 2834 Pharmaceutical Preparations